Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Christensen, J. E.
Right arrow Articles by Thomsen, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, J. E.
Right arrow Articles by Thomsen, A. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 13, No. 4, 593-600, April 2001
© 2001 Japanese Society for Immunology

CD11b expression as a marker to distinguish between recently activated effector CD8+ T cells and memory cells

J. Erbo Christensen, S. Ørding Andreasen, J. Pravsgaard Christensen and A. Randrup Thomsen

Institute of Medical Microbiology and Immunology, University of Copenhagen, Panum Institute, 3C Blegdamsvej, 2200 Copenhagen N, Denmark

Correspondence to: A. Randrup Thomsen

CD8+ T cells in different activation states have been difficult to identify phenotypically. In this study we have investigated whether Mac-1 (CD11b) expression can be used as a criterion to distinguish between recently activated effector cells and memory cells belonging to the CD8+ T cell subset. Polyclonal virus-specific effector and memory CD8+ T cells from lymphocytic choriomeningitis- and vesicular stomatitis virus-infected mice were visualized through staining for intracellular IFN-{gamma} or binding of MHC–peptide tetramers, and Mac-1 expression was evaluated. Naive T cells and most virus-specific memory CD8+ T cells express little or no Mac-1 independent of the virus model employed. In contrast, the majority of CD8+ T cells present during acute infection express a significant level of Mac-1 and, similarly, Mac-1 expression is found on secondary effectors generated in response to viral re-exposure. We therefore suggest that high Mac-1 expression defines a subset of circulating effector cells and that the presence of this marker on antigen-specific CD8+ T cells signifies recent activation.

Keywords: T cell memory, T cell phenotype, viral infection

Transmitting editor: A. McMichael


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
A. R. Thomsen
Lymphocytic Choriomeningitis Virus-Induced Central Nervous System Disease: a Model for Studying the Role of Chemokines in Regulating the Acute Antiviral CD8+ T-Cell Response in an Immune-Privileged Organ
J. Virol., January 1, 2009; 83(1): 20 - 28.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Iking-Konert, T. Vogl, B. Prior, C. Wagner, O. Sander, E. Bleck, B. Ostendorf, M. Schneider, K. Andrassy, and G. M. Hansch
T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils
Rheumatology, May 1, 2008; 47(5): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. Bunpo, B. Murray, J. Cundiff, E. Brizius, C. J. Aldrich, and T. G. Anthony
Alanyl-Glutamine Consumption Modifies the Suppressive Effect of L-Asparaginase on Lymphocyte Populations in Mice
J. Nutr., February 1, 2008; 138(2): 338 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. O. Andreasen, A. R. Thomsen, V. E. Koteliansky, T. I. Novobrantseva, A. G. Sprague, A. R. de Fougerolles, and J. P. Christensen
Expression and Functional Importance of Collagen-Binding Integrins, {alpha}1{beta}1 and {alpha}2{beta}1, on Virus-Activated T Cells
J. Immunol., September 15, 2003; 171(6): 2804 - 2811.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.